Carbometrics, in collaboration with Novo Nordisk and University of Bristol has published a paper in Nature magazine on the Glucose Sensitive Insulin.
As Selvedge Venture, we are very proud of the work Carbometrics has done and are looking forward to witnessing the many different ways they inspire innovation in diabetes care and contribute to improved patient outcomes.
Their groundbreaking research not only paves the way for advanced treatment options but also underscores the importance of collaborative efforts in the scientific community. We anticipate exciting developments as they continue to push the boundaries of what’s possible in healthcare.
